Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

3 Oct 2011 07:00

RNS Number : 3414P
Tarsus Group PLC
03 October 2011
 



Tarsus Group plc

3 October 2011

Disposal of French Joint Venture

and

Trading Update

Modamont - France

 

Tarsus Group plc ('Tarsus', the 'Group' or the 'Company'), the international business-to-business media group, is pleased to announce that it has reached agreement to dispose of its 51 per cent. interest in the joint venture, Modamont SAS ("Modamont"), to its joint venture partner, Premiere Vision SAS, for a total consideration of €6.1 million (the "Disposal").

 

Modamont is the leading exhibition for fashion accessories in France and takes place bi-annually in Paris in February and September. In the year ended 31 December 2010 Tarsus's 51 per cent. share of Modamont revenues and profits were approximately €2.2 million and €0.6 million respectively. Tarsus's share of Modamont's net assets were approximately €0.7 million as at 30 September 2011. Tarsus's share of Modamont's gross assets as at 30 June 2011 were approximately €1.5 million. At completion, Tarsus France SAS will repay a loan of €2.2 million to Modamont. The net proceeds from the Disposal will be used to give additional flexibility to the Company's balance sheet.

 

Owing to its significant shareholding in Modamont, Premiere Vision is considered to be a related party for the purposes of the Listing Rules and the Disposal therefore constitutes a related party transaction. Consequently, the Disposal is subject to and conditional upon the approval of shareholders in the Company at a general meeting. Further details of the Disposal and a notice convening a general meeting to approve the Disposal will be sent to Tarsus shareholders in due course.

 

Trading Update

 

Since the announcement of the Group's interim results on 27 July 2011, the Group has held three major exhibitions. Off Price took place in Las Vegas in August 2011 and generated a like-for-like revenue increase of approximately 6 per cent. Modamont and Labelexpo Europe (the second largest show in the Group's portfolio, held in Brussels) both took place in September and produced like-for-like revenue increases of 9 per cent. and over 10 per cent. respectively, both slightly ahead of management's expectations. The Group's largest event in the fourth quarter, the Dubai Airshow, is on track to meet management's expectations.

 

Forward bookings continue to be strong and the Board is increasingly confident of good progress being made this year.

 

Douglas Emslie, Group Managing Director of Tarsus, commented:

 

"The disposal of Modamont will materially reduce our exposure to the lower growth European market and less than 10 per cent. of Group profits will now be generated from France. Tarsus France will continue to focus on its remaining wholly owned portfolio of exhibitions.

 

We now have greater financial flexibility to accelerate our drive into the faster growth emerging markets where we are actively pursuing potential acquisitions. As we continue to execute our growth strategy we anticipate a further significant increase in the proportion of our business coming from the emerging markets".

 

For further information, please contact:

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Dan O'Brien, Group Finance Director 020 8846 2700

 

Media

Madano Partnership:

Matthew Moth 020 7593 4000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUROSRAVAKOAR
Date   Source Headline
17th Mar 20114:31 pmRNSHolding(s) in Company
17th Mar 20114:28 pmRNSAcquisition
10th Mar 201112:00 pmRNSDirector/PDMR Shareholding
7th Mar 20117:00 amRNSFinal Results
21st Jan 201110:42 amRNSAdditional Listing
18th Jan 20114:36 pmRNSHolding(s) in Company
18th Jan 20114:36 pmRNSHolding(s) in Company
6th Jan 20117:00 amRNSTrading Statement
5th Jan 20114:29 pmRNSHolding(s) in Company
5th Jan 20114:27 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20103:02 pmRNSScrip Dividend Circular
30th Nov 20102:37 pmRNSTotal Voting Rights
16th Nov 20107:00 amRNSInterim Management Statement
9th Nov 20104:58 pmRNSBlocklisting Interim Review
17th Sep 20104:55 pmRNSChange of Registered Office
31st Aug 20109:55 amRNSTotal Voting Rights
25th Aug 20106:14 pmRNSHolding(s) in Company
25th Aug 20106:12 pmRNSHolding(s) in Company
25th Aug 20106:11 pmRNSHolding(s) in Company
25th Aug 20106:09 pmRNSHolding(s) in Company
25th Aug 20106:07 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSCompletion of Acquisition and Total Voting Rights
20th Aug 20104:14 pmRNSDirector/PDMR Shareholding
19th Aug 20101:50 pmRNSResult of Meeting
18th Aug 201010:55 amRNSInterim Financial Statements 2010
17th Aug 201010:41 amRNSDirector/PDMR Shareholding
30th Jul 201010:53 amRNSTotal Voting Rights
28th Jul 20107:01 amRNSPosting of Circular
28th Jul 20107:00 amRNSInterim Results
26th Jul 20103:22 pmRNSApplication for Admission
5th Jul 20103:55 pmRNSApplication for admission
30th Jun 20107:00 amRNSPre-close Trading Statement
17th Jun 20105:10 pmRNSDirector/PDMR Shareholding
16th Jun 20102:48 pmRNSResult of AGM
7th Jun 20102:31 pmRNSCirc re. Scrip Dividend
14th May 201012:21 pmRNSAmendment to Notice of Annual General Meeting
10th May 20104:58 pmRNSAnnual Information Update
10th May 20107:00 amRNSInterim Management Statement
7th May 201011:14 amRNSBlocklisting Six Monthly Return
30th Apr 201010:05 amRNSTotal Voting Rights
13th Apr 20105:31 pmRNSDirector/PDMR Shareholding
12th Apr 20101:36 pmRNSAnnual Reports and Accounts
9th Apr 20104:44 pmRNSHolding(s) in Company
1st Apr 20104:33 pmRNSNotification of Interests in Shares
31st Mar 20109:48 amRNSTotal Voting Rights
8th Mar 20107:00 amRNSAcquisition
8th Mar 20107:00 amRNSFinal Results
5th Mar 20107:00 amRNSDirectorate Change
22nd Feb 20107:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.